Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Integra Artifical Skin receives CE Mark certification

March 27, 1998

Phase III trials of Microsponge-entrapped 5-FU begin in the U.S.

March 27, 1998

New retinoid-like compounds discovered at Allergan

March 25, 1998

Life Medical Sciences receives FDA approval to begin Repel-CV trials

March 25, 1998

FK-506: a topical agent for the treatment of moderate to severe atopic dermatitis

March 25, 1998

Positive trial results reported for AlloDerm

March 24, 1998

Potential new indication for zafirlukast in the treatment of urticaria

March 23, 1998

PSSO: an alternative to hydrocortisone for the treatment of erythema

March 23, 1998

Schering-Plough and Chugai sign marketing agreement for psoriasis drug

March 20, 1998

Botox effective in controlling focal hyperhidrosis

March 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...